Logo for Sprint Bioscience

Sprint Bioscience Investor Relations Material

Latest events

Logo for Sprint Bioscience

Q3 2024

30 Oct, 2024
Logo for Sprint Bioscience

Q2 2024

28 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Sprint Bioscience

Access all reports
Sprint Bioscience AB is a Swedish biotechnology company focused on developing innovative cancer therapies. It specializes in drug discovery for oncology, leveraging a fragment-based drug discovery (FBDD) platform to accelerate the identification of promising molecules for cancer treatment. The company's research pipeline includes drug candidates targeting cancer metabolism and autophagy, with the aim of enhancing therapeutic approaches for hard-to-treat cancers. It is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.